clinical trial · NCT05967351
A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study
Duchenne Muscular Dystrophydelandistrogene moxeparvovec
brief summary
The purpose of this study is to provide a single clinical study with a uniform approach to monitoring long-term safety and efficacy in participants who received delandistrogene moxeparvovec in a previous clinical study. No study drug will be administered as part of this study.
started
Sep 27, 2023
primary completion
Oct 31, 2033
completion
Oct 31, 2033
last updated
Feb 6, 2026
official title
A Phase 3, Multinational, Long-term Follow-up Study to Evaluate Safety and Efficacy in Subjects Who Have Previously Received SRP-9001 in a Clinical Study
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol